GlassScriptPhysician profile
Mandeep S Randhawa
NPI 1255562138
$12,248.85
in general payments reported to CMS, 2019-2025
26 companies · $5,614 in 2025
The $5,614 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,304 · 2020: $418 · 2021: $2,312 · 2022: $1,338 · 2023: $570 · 2024: $694 · 2025: $5,614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,269 · Travel and Lodging: $2,608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,268.85 |
| Travel and Lodging | $2,608.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,876.36 | 2019-2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $2,363.87 | 2019-2025 | General - Vascular Access, Watchman Flx, Avvigo Guidance System |
| Abiomed | $1,648.63 | 2021-2025 | Impella |
| Abbott Laboratories | $1,537.27 | 2019-2025 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit, Assurity |
| Medtronic, INC. | $1,435.21 | 2021-2025 | Micra, Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $438.48 | 2019-2025 | Lifevest |
| Inari Medical, INC. | $293.55 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $263.32 | 2019-2022 | |
| Medtronic Vascular, INC. | $237.40 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $170.41 | 2021-2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $124.29 | 2019 | |
| Cardiovascular Systems INC. | $120.33 | 2019 | |
| Philips North America LLC | $106.88 | 2020 | |
| Merck Sharp & Dohme LLC | $75.43 | 2022-2023 | Verquvo |
| Amgen INC. | $71.55 | 2019-2025 | Repatha |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $71.44 | 2023-2025 | Gore Cardioform Septal Occluder |
| Angiodynamics, INC. | $68.91 | 2021 | |
| Penumbra, INC. | $65.97 | 2019 | |
| Shockwave Medical, INC | $63.03 | 2022 | |
| Cardinal Health 200 LLC | $42.77 | 2020 | |
| Cardiva Medical, INC. | $42.18 | 2024 | Optowire |
| E.R. Squibb & Sons, L.L.C. | $42.12 | 2019 | |
| Chiesi USA, INC. | $29.38 | 2022 | |
| Cvrx, INC. | $27.58 | 2024 | Barostim Neo System |
| Biosense Webster, INC. | $17.25 | 2025 | Nuvision Ice Catheter |
| Biotronik INC. | $15.24 | 2023 | Biomonitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandeep Randhawa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.